Posted by AGORACOM-JC
at 6:07 PM on Tuesday, February 2nd, 2021
On October 1st, the Ontario Securities Commission (OSC) and Investment Industry Regulatory Organization of Canada (IIROC) issued a press release in which they stated:
“As outlined in joint whistleblower guidance published today, the OSC and IIROC have reason to believe that certain market participants may be engaged in abusive short selling practices.”
and then announced this MASSIVE BOUNTY on predatory short sellers:
“Those who provide information to the OSC Whistleblower Program may be eligible for awards of up to $5 million for tips that lead to an OSC enforcement action.”
What effect has this had on the smallcap markets? Let’s look at the TSX Venture Index
On behalf of all small cap issuers, investors and service providers, we’re grateful to the OSC and IIROC for stepping up and putting their foot down.
However, none of this would have happened if it were not for the efforts of “Save Canadian Mining”, the lobbyist/advocacy group founded by Terry Lynch and backed by industry giants such as Eric Sprott, Sean Roosen, Keith Neumeyer and Rob McEwen and 3,000 + small cap investors who wrote the cheques necessary to hire the experts and analysts to help SCM make their case.
As such, if your Canadian small cap stock or stocks have appreciated nicely over the past 2 1/2 months without being hit by predatory short seller attacks, we should all be thanking SCM for their relentless and tireless work.
To this end, we were happy to interview Terry Lynch to find out if this 8 year nightmare is over and what final steps they are hoping to achieve with the Ontario Provincial Government, OSC, IIROC and CSA over the next 90 days to finally put an end to this. Watch this great interview.
Posted by AGORACOM-JC
at 8:44 AM on Monday, February 1st, 2021
Closed on the first $2.5 million of the $4 million Non-brokered Private Placement of Convertible Debenture Loan Notes each with a face value of $50,000 as originally announced in its Press Release dated January 25, 2021.
On January 27 and 28, 2021, there were closings of 40 and 10 Convertible Notes respectively, raising gross proceeds of $2.5 million.
MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) is pleased to announce that it has closed on the first $2.5 million of the $4 million Non-brokered Private Placement of Convertible Debenture Loan Notes each with a face value of $50,000 (“Convertible Notes”) as originally announced in its Press Release dated January 25, 2021. On January 27 and 28, 2021, there were closings of 40 and 10 Convertible Notes respectively, raising gross proceeds of $2.5 million. The Convertible Notes will bear interest at 6% per year, payable Quarterly, and will mature on December 31, 2023 (the “Maturity Date”). The Convertible Notes may be converted, at the option of the Holder, into units at $0.14 per unit (“Unit”) at any time until the Maturity Date. Each Unit will be comprised of One (1) fully paid Common Share and One-half (1/2) of a Share Purchase Warrant. Each whole Share Purchase Warrant will be exercisable to purchase One (1) further Common Share at the price of $0.20, exercisable for a period expiring on the Maturity Date. The Company anticipates that it will close on further issuances of up to 30 more Convertible Notes, for up to a further $1.5 million. Closings will be subject to receipt of subscriptions and a number of other conditions, including without limitation the receipt of all relevant regulatory and Stock Exchange approvals or acceptances. The Convertible Notes, and any underlying securities, are subject to restriction from trading for a period of four months and one day from the respective dates of issuance. Qualified Agents may receive commissions in respect of subscriptions introduced by them by way of cash equal to 6% of funds so introduced, and issuance of agent’s warrants (“Agent’s Warrant(s)”) calculated by reference to 6% of the funds from subscribers introduced by such Agent. Each Agent’s Warrant, which is non-transferable, will be exercisable to acquire one Unit at $0.14 per Unit, at any time during the period up to the Maturity Date. In relation to the Closings already completed, a total of $129,000 has been paid by way of cash commissions and 407,143 Agent’s Warrants were issued. The Agent’s Warrants, and any underlying securities, are restricted from trading for a period of four months and one day from their respective dates of issuance.
Posted by AGORACOM-JC
at 8:28 AM on Monday, February 1st, 2021
Entered into an exclusive master distributor agreement with Air Alpine Innovation Research Inc. to promote and market Air Sniper products.
UPI’s wholly-owned subsidiary, VCI Controls Inc. will exclusively distribute these products in Ontario, Quebec and Atlantic Canada.
“We are excited to exclusively represent this Made-in-Canada success story of leading edge germicidal UVC and NASA-originated Photocatalytic Oxidation technology in Ontario, Quebec and Atlantic Canada,” stated Chris Hazelton,
Toronto, Ontario–(February 1, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company“) is pleased to announce that it has entered into an exclusive master distributor agreement (“Agreement“) with Air Alpine Innovation Research Inc. (“Air Sniper“) to promote and market Air Sniper products. UPI’s wholly-owned subsidiary, VCI Controls Inc. (“VCI“) will exclusively distribute these products in Ontario, Quebec and Atlantic Canada.
“We are excited to exclusively represent this Made-in-Canada success story of leading edge germicidal UVC and NASA-originated Photocatalytic Oxidation technology in Ontario, Quebec and Atlantic Canada,” stated Chris Hazelton, President and CEO of UPI. “We will aggressively pursue immediate opportunities in schools, campuses, government and commercial facilities and seniors’ homes.”
Stuart Henley, President of Air Sniper said, “Air Sniper is pleased to enter into a partnership with Universal PropTech, and to be able to utilize their 40-year presence and experience in Ontario, Quebec and Atlantic Canada. With UPI’s existing and expanding client footprint, we expect to develop a strong partnership and see significant adoption as we work to push the Air Sniper product through sales funnels.”
Posted by AGORACOM-JC
at 7:58 PM on Sunday, January 31st, 2021
Beyond Meat has become an $11 BILLION company by creating products designed to emulate beef. The basis of success has come from delivering the experience meat eaters have come to love (hamburgers, hot dogs, etc.) while also achieving the goal of eating healthier.
TAAT™ Beyond Tobacco™ mimics the experiences of cigarettes without nicotine or tobacco. It is engineered to closely emulate the sensory components of smoking a tobacco cigarette, including tasting and smelling just like tobacco.
E-cigarettes and vaping have failed despite existing for 15 years, driving most smokers back to cigarettes because they only perpetuate the problem of nicotine addiction while delivering a completely different user experience to smokers.
Under the leadership of experienced veterans from the tobacco industry, including and especially Philip Morris International, TAAT™ launched in the United States Just 7 weeks ago and has already received repeat orders from more than 60% of convenience and gas station customers.
How good was this launch?
“Out of all of the tobacco category products I have worked with, TAAT™ is an outlier in terms of the level of demand it has had in its early stages. I have launched dozens of new tobacco brands across Canada as well as in the Caribbean, and while many of the new products were reordered by retailers in their first several weeks on the market, none of them were reordered by anywhere near 60% of stores that initially carried them. …. I have confidence that we could replicate these outcomes both in Ohio and in other markets where we may introduce TAAT™ in the future.” – TAAT Chief Revenue Officer Tim Corkum (former commercialization executive for Philip Morris International)
How big is the market TAAT is going after? Tobacco is used by:
34M adults in America, equating to 215 BILLION cigarettes sold in 2018
1.3 billion people worldwide
… and almost all of them aspire to leave nicotine behind. Beyond Tobacco™ from TAAT is about to give them what they want and, if they succeed, give shareholders “Beyond Belief” returns in the next 2-3 years.
Watch this great interview with CEO Setti Coscarella!
Posted by AGORACOM-JC
at 10:32 AM on Thursday, January 28th, 2021
Tim Daniels / Executive Chairman of AI/ML Innovations Inc. / (CSE:AIML / OTC:FIRZF) explains how the Toronto-based business is focusing on acquiring and furthering Artificial Intelligence and Machine Learning technologies that can address urgent societal needs.
The firm’s key subsidiary, Health Gauge, is a leading digital health solutions provider that’s poised to disrupt the traditional healthcare industry by providing A.I. innovations and services that improve health outcomes, while at the same time reducing costs and stresses on the overburdened healthcare infrastructure.
AI/ML Highlights:
Recently showcased its proof-of-concept deployment in a study funded by The Bill and Melinda Gates Foundation
Health Gauge aims to penetrate the $245bn global digital health monitoring market by partnering with leading channel partners, health benefits providers, and end-users
Will do this via its proprietary combination of digital health monitoring devices, AI-based software, and cloud computing platform.
Take a seat and learn more about AI/ML and its ambitious vision for the future.
Posted by AGORACOM-JC
at 9:30 AM on Thursday, January 28th, 2021
Phil Waddington / President and CEO of Molecule Holdings Inc. / (MLCL:CSE) discusses the craft-focused, cannabis beverage production company’s cutting-edge work in the nascent Canadian market.
Boasting a 200,000 square foot production facility based in Ontario, the company has just been given the green light to begin selling its unique line of cannabis-infused beverages throughout Canada, starting in Ontario and Québec.
The company’s recent partnership with Vortex Cannabis Inc. allows Molecule to bring its unique line of cannabis-infused beverage products to market this year, while completing its own sales amendment application.
Molecule Highlights:
Molecule’s recent deal with Vortex Cannabis Inc. allows it to begin selling its unique line of cannabis-infused beverages throughout Canada this year.
Vortex will sell products produced by Molecule to provincial retailers, starting with Ontario and Québec.
Molecule has a 200,000 square foot production facility based in Ontario, offering huge capacity.
The company forecasts 2021 Q1 revenue of $3.5m, 2021 Q2 revenue of $5.8m, and a 2021 Run Rate revenue of $18.5m
An early leap of faith into this emerging industry in 2018 has positioned the company well ahead of the pack now.
“We are excited to move into full scale production and sale,” says CEO Phil Waddington.
Posted by AGORACOM-JC
at 9:08 AM on Thursday, January 28th, 2021
Announced a strategic partnership with STEM Sports® with the goal of contributing to a Binovi Connect enabled curriculum for their K-8 programs.
STEM Sports® provides a turnkey K-8 supplemental curriculum that uses sports as the real-life application to drive STEM-based learning in classrooms, after-school programs, and camps.
STEM Sports® programs are currently active in a variety of school districts within 49 of the 50 US states.
January 28, 2021 – Toronto, New York – Binovi Technologies Corp., (Binovi) (TSXV:VISN ) | ( OTC:BNVIF ) | ( GR:2EYA), a leader in neuro-vision performance technology, is proud to announce a strategic partnership with STEM Sports® with the goal of contributing to a Binovi Connect enabled curriculum for their K-8 programs. STEM Sports® provides a turnkey K-8 supplemental curriculum that uses sports as the real-life application to drive STEM-based learning in classrooms, after-school programs, and camps. STEM Sports® programs are currently active in a variety of school districts within 49 of the 50 US states. Additionally, STEM Sports® has been awarded a STEM.orgAccredited™ Educational Experience trustmark!STEM.org Educational Research is the longest operating, privately held, STEM education research and credentialing organization in America, serving over 4,500 schools, districts, and organizations in over 25 countries.
“Investing in STEM-focused or STEM-based programs has proven time and time again to be a powerful way for companies to give back and to help promote new avenues of thinking. With this partnership, Binovi is teaming up with an already strong group in STEM Sports® to develop an important set of skills that often go overlooked. We’re excited for how Jeff and his team will be able to improve the lives —in the classroom, on the field, and in everyday life— of these young minds,” said Adam Cegielski, Binovi Founder & CEO.
“We have and will continue to collaborate with partners that see the value in investing in the education of today’s students so that they can enhance the future workforce. Binovi literally sees the opportunity to enhance the technology aspects that we provide in our curricula to the benefit of K-8 schools and afterschool programs,” said Jeff Golner, STEM Sports® President & CEO.
“Using athletics as a vehicle for learning is a powerful way to instill real-life skills into young minds that will drive them to succeed both in the game and in life. By joining forces with STEM Sports®, we aim to open their student athletes’ eyes to these new skills, as well as tools to promote skill advancement and performance improvement that will serve them in the same way now and throughout their lives,” commented Tania Archer, Binovi Head of Commercialization & Strategic Partnerships.
Posted by AGORACOM-JC
at 8:15 AM on Thursday, January 28th, 2021
Announced significant milestones at its Cedar Psychiatry clinics: administering over 5,000 ketamine treatments and over 2,000 Spravato™ treatments.
Clients receiving ketamine treatment at Novamind’s Cedar Psychiatry clinics are offered specialized therapy, pre- and post-ketamine-administration (ketamine-assisted psychotherapy).
Cedar Psychiatry specializes in evidence-based therapeutic protocols that facilitate the integration of ketamine experiences and optimize treatment outcomes for clients.
TORONTO, ON / January 28, 2021 / Novamind Inc. (CSE:NM) (“Novamind”), a leading mental health company specialized in psychedelic medicine, is proud to announce significant milestones at its Cedar Psychiatry clinics: administering over 5,000 ketamine treatments and over 2,000 Spravato™ treatments.
Launched in 2016, Cedar Psychiatry is a leading provider of innovative, evidence-based mental health therapies in the United States.
Clients receiving ketamine treatment at Novamind’s Cedar Psychiatry clinics are offered specialized therapy, pre- and post-ketamine-administration (ketamine-assisted psychotherapy). Cedar Psychiatry specializes in evidence-based therapeutic protocols that facilitate the integration of ketamine experiences and optimize treatment outcomes for clients.
The number of ketamine treatments administered at Cedar Psychiatry clinics grew 90% from 2019 to 2020. During the same period, total Spravato™ treatments at Cedar Psychiatry clinics have grown over 400%. Spravato™ is a version of ketamine that was approved by the U.S. FDA for treatment-resistant depression (TRD) in March 2019, and for major depressive disorder (MDD) with suicidal ideation or behaviour in August 2020. Clinical research studies that supported FDA approval showed that Spravato™ can effectively benefit people with these conditions, which can be difficult to treat.
“Spravato™ requires specialized infrastructure and processes that can be difficult for small mental health practices to implement, but Cedar Psychiatry has the scale and expertise to effectively manage the challenges of offering these novel medications to our clients,” commented Dr. Reid Robison, Chief Medical Officer and Director of Novamind.
“The need for innovative mental health services has never been greater. This demand is reflected in a sharp increase in visits to our clinics, and the growing adoption by our clients of alternative mental health treatments” added Yaron Conforti, CEO and Director of Novamind.
Posted by AGORACOM-JC
at 10:31 AM on Wednesday, January 27th, 2021
Agreed to increase the size of the Placement.
The Company will now issue up to 14,706,000 units from the treasury of the Company, at a price of $0.85 per Unit for total gross proceeds of up to approximately $12.5 million (the “ Placement ”).
TORONTO, Jan. 27, 2021 — POET Technologies Inc. (“ POET ” or the “ Company ”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, is pleased to announce that in connection with the private placement (the “ Placement ”) announced by the Company earlier today, the Company and a syndicate of agents led by Cormark Securities Inc., and including IBK Capital Corp. and PI Financial Corp. (collectively, the “ Agents ”), have agreed to increase the size of the Placement. The Company will now issue up to 14,706,000 units (the “ Units ”) from the treasury of the Company, at a price of $0.85 per Unit (the “ Issue Price ”) for total gross proceeds of up to approximately $12.5 million (the “ Placement ”).
In addition, the Company and the Agents have also agreed that the Agents shall have an option (the “ Agents’ Option ”) to purchase up to an additional 2,941,200 Units on the same terms, exercisable up until the time of closing of the Placement, for market stabilization purposes and to cover over-allotments, if any. If the Agents’ Option is exercised in full, an additional approximately $2.5 million will be raised and the aggregate proceeds of the Placement will be up to approximately $15.0 million.
In connection with the Placement, the Company will pay a cash commission to the Agents equal to 6.0% of the aggregate gross proceeds of the Placement and will issue broker warrants equal to 6.0% of the number of Units sold under the Placement, each exercisable to acquire one Common Share at the Issue Price for a period of 24 months from the closing date of the Placement.
Posted by AGORACOM-JC
at 8:20 AM on Wednesday, January 27th, 2021
Entered into a partnership with AtmosAir Solutions of Fairfield CT. to bring its products to market in Canada, including the company’s bi-polar ionization technology that mitigates COVID-19 and other viruses, bacteria and mold in the air and on surfaces.
UPI’s wholly-owned subsidiary, VCI Controls Inc. will promote, market, and sell AtmosAir products in Ontario and Quebec.
Toronto, Ontario–(January 27, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company“) announced today that is has entered into a partnership with AtmosAir Solutions of Fairfield CT. to bring its products to market in Canada, including the company’s bi-polar ionization technology that mitigates COVID-19 and other viruses, bacteria and mold in the air and on surfaces. UPI’s wholly-owned subsidiary, VCI Controls Inc. (“VCI”) will promote, market, and sell AtmosAir products in Ontario and Quebec.
“Our team is very excited to be taking this important step in our business plan with a reputable company such as AtmosAir,” said Chris Hazelton, President and CEO of UPI. “Their impressive client base is a testament to the quality of their solutions, and it is time such great technology was made readily available to our clients – existing and future. UPI is committed to seeking out the best-in-class technology solutions for our clients to fight the spread of COVID-19 whether by way of ownership, investment, licencing or master distribution arrangements. We are excited and committed to aggressively pursue schools, universities and colleges, long term care facilities and other governmental facilities to deliver results with our 40-year proven integrated HVAC and Building Controls company.”
Carlos Gendron, VP of Sales and Marketing at AtmosAir said, “Our current distribution has reached over 7,500 installations worldwide, mainly focused on United States and China. The quality of our products is evident from our roster of clients, which include marquee names involved in commercial real estate, health care, hospitals, assisted living, hotels, cruise lines, universities and sports facilities. We are pleased to work with the UPI team as we make our debut into Ontario and Quebec. VCI’s experience and long-standing track record is impressive and we look forward to showcasing our innovation in Canada with a credible partner such as UPI.”
AtmosAir products provide indoor air quality solutions that suppress airborne and surface microbials and pathogens, including coronavirus, other viruses, bacteria and mold, and reduce odors as well as unhealthy and irritating volatile organic compounds (VOCs). AtmosAir Solutions’ tested and proven air purification technology is a continuous disinfectant, removing airborne and surface contaminants from indoor spaces.
